Abbreviations:
eMC, electronic Medicines Compendium; SPC, Summary of Product Characteristics; PIL, Patient Information Leaflet
Omjjara is a registered trademark of the GlaxoSmithKline group of companies
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or by searching for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects. Adverse events should also be reported to GSK on 0800 221 441, via email: uksafety@gsk.com or at https://gsk.public.reportum.com/
